• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期的氧化应激、亚硝化应激与组蛋白去乙酰化酶-2活性

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.

作者信息

Footitt Joseph, Mallia Patrick, Durham Andrew L, Ho W Eugene, Trujillo-Torralbo Maria-Belen, Telcian Aurica G, Del Rosario Ajerico, Chang Cheng, Peh Hong-Yong, Kebadze Tatiana, Aniscenko Julia, Stanciu Luminita, Essilfie-Quaye Sarah, Ito Kazuhiro, Barnes Peter J, Elkin Sarah L, Kon Onn M, Wong W S Fred, Adcock Ian M, Johnston Sebastian L

机构信息

Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, England; Imperial College Healthcare NHS Trust, London, England; Centre for Respiratory Infection, Imperial College, London, England.

Airways Disease Section, National Heart and Lung Institute, Imperial College, London, England.

出版信息

Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.

DOI:10.1378/chest.14-2637
PMID:25790167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4700054/
Abstract

BACKGROUND

Respiratory virus infections are commonly associated with COPD exacerbations, but little is known about the mechanisms linking virus infection to exacerbations. Pathogenic mechanisms in stable COPD include oxidative and nitrosative stress and reduced activity of histone deacetylase-2 (HDAC2), but their roles in COPD exacerbations is unknown. We investigated oxidative and nitrosative stress (O&NS) and HDAC2 in COPD exacerbations using experimental rhinovirus infection.

METHODS

Nine subjects with COPD (Global Initiative for Chronic Obstructive Lung Disease stage II), 10 smokers, and 11 nonsmokers were successfully infected with rhinovirus. Markers of O&NS-associated cellular damage, and inflammatory mediators and proteases were measured in sputum, and HDAC2 activity was measured in sputum and bronchoalveolar macrophages. In an in vitro model, monocyte-derived THP-1 cells were infected with rhinovirus and nitrosylation and activity of HDAC2 was measured.

RESULTS

Rhinovirus infection induced significant increases in airways inflammation and markers of O&NS in subjects with COPD. O&NS markers correlated with virus load and inflammatory markers. Macrophage HDAC2 activity was reduced during exacerbation and correlated inversely with virus load, inflammatory markers, and nitrosative stress. Sputum macrophage HDAC2 activity pre-infection was inversely associated with sputum virus load and inflammatory markers during exacerbation. Rhinovirus infection of monocytes induced nitrosylation of HDAC2 and reduced HDAC2 activity; inhibition of O&NS inhibited rhinovirus-induced inflammatory cytokines.

CONCLUSIONS

O&NS, airways inflammation, and impaired HDAC2 may be important mechanisms of virus-induced COPD exacerbations. Therapies targeting these mechanisms offer potential new treatments for COPD exacerbations.

摘要

背景

呼吸道病毒感染通常与慢性阻塞性肺疾病(COPD)急性加重相关,但病毒感染与急性加重之间的联系机制知之甚少。稳定期COPD的发病机制包括氧化应激和亚硝化应激以及组蛋白去乙酰化酶2(HDAC2)活性降低,但其在COPD急性加重中的作用尚不清楚。我们使用实验性鼻病毒感染研究了COPD急性加重期的氧化应激和亚硝化应激(O&NS)以及HDAC2。

方法

9名COPD患者(慢性阻塞性肺疾病全球倡议II期)、10名吸烟者和11名非吸烟者成功感染鼻病毒。检测痰液中O&NS相关细胞损伤标志物、炎症介质和蛋白酶,并检测痰液和支气管肺泡巨噬细胞中的HDAC2活性。在体外模型中,用鼻病毒感染单核细胞衍生的THP-1细胞,检测HDAC2的亚硝化作用和活性。

结果

鼻病毒感染导致COPD患者气道炎症和O&NS标志物显著增加。O&NS标志物与病毒载量和炎症标志物相关。急性加重期巨噬细胞HDAC2活性降低,且与病毒载量、炎症标志物和亚硝化应激呈负相关。感染前痰液巨噬细胞HDAC2活性与急性加重期痰液病毒载量和炎症标志物呈负相关。鼻病毒感染单核细胞可诱导HDAC2亚硝化并降低HDAC2活性;抑制O&NS可抑制鼻病毒诱导的炎性细胞因子。

结论

O&NS、气道炎症和HDAC2功能受损可能是病毒诱导COPD急性加重的重要机制。针对这些机制的治疗方法为COPD急性加重提供了潜在的新治疗手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/95203cf95e90/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/b91f6ddd0dad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/f8b729765449/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/ceec144050cb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/95203cf95e90/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/b91f6ddd0dad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/f8b729765449/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/ceec144050cb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63df/4944778/95203cf95e90/gr4.jpg

相似文献

1
Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.慢性阻塞性肺疾病急性加重期的氧化应激、亚硝化应激与组蛋白去乙酰化酶-2活性
Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.
2
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.实验性鼻病毒感染作为慢性阻塞性肺疾病加重的人类模型。
Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.
3
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.慢性阻塞性肺疾病患者鼻病毒感染后支气管黏膜炎症与疾病严重程度的关系。
J Allergy Clin Immunol. 2020 Oct;146(4):840-850.e7. doi: 10.1016/j.jaci.2020.03.021. Epub 2020 Apr 10.
4
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.鼻病毒感染导致慢性阻塞性肺疾病中抗菌肽的降解和继发细菌感染。
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.
5
Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.气道葡萄糖在慢性阻塞性肺疾病患者细菌感染中的作用。
J Allergy Clin Immunol. 2018 Sep;142(3):815-823.e6. doi: 10.1016/j.jaci.2017.10.017. Epub 2018 Jan 5.
6
Antiviral immunity is impaired in COPD patients with frequent exacerbations.慢性阻塞性肺疾病(COPD)频繁加重患者的抗病毒免疫受损。
Am J Physiol Lung Cell Mol Physiol. 2019 Dec 1;317(6):L893-L903. doi: 10.1152/ajplung.00253.2019. Epub 2019 Sep 12.
7
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.病毒感染后慢性阻塞性肺疾病气道微生物组的衍生。
Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.
8
Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets.人类鼻病毒感染与 COPD:在加重期的作用和潜在治疗靶点。
Expert Rev Respir Med. 2020 Aug;14(8):777-789. doi: 10.1080/17476348.2020.1764354. Epub 2020 Jun 4.
9
Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients.慢性阻塞性肺疾病(COPD)患者外周血单核细胞(PBMCs)中组蛋白去乙酰化酶2(HDAC2)水平降低。
PLoS One. 2016 Jan 25;11(1):e0147380. doi: 10.1371/journal.pone.0147380. eCollection 2016.
10
Oxidative Stress Attenuates TLR3 Responsiveness and Impairs Anti-viral Mechanisms in Bronchial Epithelial Cells From COPD and Asthma Patients.氧化应激可减弱 COPD 和哮喘患者支气管上皮细胞中 TLR3 的反应性并损害抗病毒机制。
Front Immunol. 2019 Nov 29;10:2765. doi: 10.3389/fimmu.2019.02765. eCollection 2019.

引用本文的文献

1
Viruses in bronchiectasis.支气管扩张症中的病毒
ERJ Open Res. 2025 Sep 1;11(5). doi: 10.1183/23120541.01131-2024. eCollection 2025 Sep.
2
Diagnostic Challenges and Pathogenetic Differences in Biomass-Smoke-Induced versus Tobacco-Smoke-Induced COPD: A Comparative Review.生物质烟雾诱导与烟草烟雾诱导的慢性阻塞性肺疾病的诊断挑战和发病机制差异:一项比较性综述
Diagnostics (Basel). 2024 Sep 27;14(19):2154. doi: 10.3390/diagnostics14192154.
3
Epigenetic regulation of macrophage activation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中巨噬细胞激活的表观遗传调控。

本文引用的文献

1
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者实验性鼻病毒感染中的淋巴细胞亚群
Respir Med. 2014 Jan;108(1):78-85. doi: 10.1016/j.rmed.2013.09.010. Epub 2013 Sep 22.
2
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD.慢性阻塞性肺疾病实验性鼻病毒感染中的中性粒细胞黏附分子。
Respir Res. 2013 Jul 8;14(1):72. doi: 10.1186/1465-9921-14-72.
3
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病患者的皮质类固醇抵抗。
Front Immunol. 2024 Aug 14;15:1445372. doi: 10.3389/fimmu.2024.1445372. eCollection 2024.
4
Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbations.中性粒细胞胞外陷阱促进病毒诱导的 COPD 加重的免疫发病机制。
Nat Commun. 2024 Jul 9;15(1):5766. doi: 10.1038/s41467-024-50197-0.
5
Infection and the microbiome in bronchiectasis.支气管扩张症中的感染和微生物组。
Eur Respir Rev. 2024 Jul 3;33(173). doi: 10.1183/16000617.0038-2024. Print 2024 Jul.
6
Efficacy of treatment with N-acetylcysteine inhalation for AECOPD: A propensity-score-matched cohort study.乙酰半胱氨酸吸入治疗 AECOPD 的疗效:一项倾向评分匹配队列研究。
Clin Respir J. 2023 Oct;17(10):1038-1047. doi: 10.1111/crj.13690. Epub 2023 Aug 24.
7
COPD Patients Exhibit Distinct Gene Expression, Accelerated Cellular Aging, and Bias to M2 Macrophages.COPD 患者表现出独特的基因表达、加速的细胞衰老和偏向 M2 巨噬细胞。
Int J Mol Sci. 2023 Jun 8;24(12):9913. doi: 10.3390/ijms24129913.
8
The therapeutic potential of quercetin for cigarette smoking-induced chronic obstructive pulmonary disease: a narrative review.槲皮素治疗吸烟诱导的慢性阻塞性肺疾病的潜力:叙事性综述。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231170800. doi: 10.1177/17534666231170800.
9
Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells.过氧化氢可减轻鼻病毒诱导的鼻黏膜上皮细胞抗病毒干扰素分泌。
Front Immunol. 2023 Feb 13;14:1086381. doi: 10.3389/fimmu.2023.1086381. eCollection 2023.
10
The Biological Processes of Ferroptosis Involved in Pathogenesis of COVID-19 and Core Ferroptoic Genes Related With the Occurrence and Severity of This Disease.铁死亡的生物学过程与COVID-19发病机制的关系以及与该疾病发生和严重程度相关的核心铁死亡基因。
Evol Bioinform Online. 2023 Feb 13;19:11769343231153293. doi: 10.1177/11769343231153293. eCollection 2023.
J Allergy Clin Immunol. 2013 Mar;131(3):636-45. doi: 10.1016/j.jaci.2012.12.1564. Epub 2013 Jan 26.
4
Antibiotics for exacerbations of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病急性加重期的抗生素
Cochrane Database Syst Rev. 2012 Dec 12;12:CD010257. doi: 10.1002/14651858.CD010257.
5
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial.TNFα 拮抗剂治疗 COPD 急性加重期:一项随机双盲对照试验。
Thorax. 2013 Feb;68(2):142-8. doi: 10.1136/thoraxjnl-2012-202432. Epub 2012 Nov 17.
6
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.鼻病毒感染导致慢性阻塞性肺疾病中抗菌肽的降解和继发细菌感染。
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.
7
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 执行摘要。
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
8
Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD.芳烃受体(AhR)在哮喘和慢性阻塞性肺疾病病理学中的作用
J Allergy (Cairo). 2012;2012:372384. doi: 10.1155/2012/372384. Epub 2012 Jan 29.
9
A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium.一项评估 AZD9668(一种新型、选择性、口服型中性粒细胞弹性蛋白酶抑制剂)在噻托溴铵治疗基础上的 COPD 患者中的安全性、耐受性、药代动力学和药效学的随机、安慰剂对照、剂量递增研究。
COPD. 2012 Apr;9(2):111-20. doi: 10.3109/15412555.2011.641803.
10
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.血液嗜酸性粒细胞指导慢性阻塞性肺疾病加重的皮质类固醇治疗:一项随机安慰剂对照试验。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55. doi: 10.1164/rccm.201108-1553OC. Epub 2012 Mar 23.